MedTrace Logo

Lipid Encapsulation for Ileal Brake Activation

NCT03025997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2017-11-20

No results posted yet for this study

Summary

This study evaluates the ability of encapsulation of orally applied lipids in a yoghurt snack to modify ad libitum food intake and satiety, without GI symptoms. Every subject receives two treatments (active, and placebo) on two different days, following a randomized cross-over design.

Conditions

  • Appetite Regulation

Interventions

DIETARY_SUPPLEMENT

Active yoghurt

Active yoghurt (containing encapsulated lipid) will be ingested after a standardized breakfast, and subsequently satiety and food intake will be measured.

DIETARY_SUPPLEMENT

Placebo yoghurt

Placebo yoghurt (containing non-encapsulated lipid) will be ingested after a standardized breakfast, and subsequently satiety and food intake will be measured.

Sponsors & Collaborators

  • Wageningen University and Research

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Adrian AM Masclee, Prof. · azM/UM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-24
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025997 on ClinicalTrials.gov